About The Cooper Companies, Inc. - Common Stock (COO)
Cooper Companies is a global medical device company that specializes in the design, manufacture, and marketing of innovative products in the eye care and women's health sectors. The company is best known for its extensive range of contact lenses, which cater to various needs including vision correction and lifestyle enhancements. Additionally, Cooper Companies offers a suite of women’s health products, particularly in the areas of fertility and other reproductive health solutions, aiming to improve the quality of life for individuals worldwide. Through its commitment to research and development, the company seeks to advance technology and provide high-quality, effective solutions for its customers. Read More
What Happened? Shares of medical device company CooperCompanies (NASDAQ:COO) fell 13.9% in the afternoon session after the company reported weak second-quart...
Medical device company CooperCompanies (NASDAQ:COO) missed Wall Street’s revenue expectations in Q2 CY2026, with sales flat year on year at $1.07 billion. Th...
Cooper Companies (NASDAQ:COO) reported third-quarter fiscal 2026 revenue of $1.066 billion, up about 1% on both a reported and organic basis, as record free cash flow and earnings growth offset pressure at its CooperVision contact lens business from planned U.S. channel inventory reductions.
Non-GA
Cooper Companies (NASDAQ:COO) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below. This transcript is brought to you by
Medical device company CooperCompanies (NASDAQ:COO) fell short of the market’s revenue expectations in Q2 CY2026, with sales flat year on year at $1.07 billi...
SAN RAMON, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2026.
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversifi...
As Treasury yields near 4.79% amid rising rates, analysts argue the borrowing-cost-versus-return spread, not the headline rate, best explains winners like ASML and GE Vernova versus laggards like Oracle and Rocket.
Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Wednesday after market close. Here’s what to expect. CooperCompanies beat...
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
Over the last six months, CooperCompanies’s shares have sunk to $75.74, producing a disappointing 9.5% loss - a stark contrast to the S&P 500’s 12.9% gain. T...
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
SAN RAMON, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report third quarter 2026 financial results on Wednesday, September 9, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
